IntroductionHematopoietic stem cells (HSCs) give rise to all blood lineages. 1 As HSCs differentiate along one lineage, they gradually lose the ability to develop into other lineages. 2 Hematopoietic differentiation involves lineage commitment, defined here as the initiation of developmental program(s) that lead to a particular cell fate. The accompanying inability to differentiate into other lineages has been referred to as lineage maintenance. 3 Lineage commitment and lineage maintenance are complementary processes that guide cell fate decisions. Thus, cells committed to a particular lineage have alternative developmental choices until lineage maintenance is complete. 4 Hematopoietic differentiation has been schematically depicted as a "tree of hematopoiesis," 1 outlining the possible developmental choices. According to this prevailing schema, the decision between lymphoid and myeloid lineages occurs very early. However, alternative views have been proposed, including the existence of a common myelo-lymphoid progenitor. 5,6 Elucidation of hematopoietic developmental pathways and extrinsic stimuli that influence them is instrumental to understanding both normal and malignant hematopoiesis. In particular, factors that favor natural killer (NK)-cell development could be used to exploit their activity against malignancies.NK cells are innate immune effector cells. Their derivation from either lymphoid or myeloid lineages was debated early in their discovery. 7 Further research showed that NK cells can be derived from common lymphoid progenitors (CLPs) and hence have been considered separate from myeloid lineage. 8,9 However, some studies question this and have shown that progenitors expressing myeloid antigens can develop into NK cells. 10,11 NKcell differentiation from hematopoietic progenitor cells (HPCs) can be studied in vitro. 12,13 This process depends on cytokines, notably interleukin-2 (IL-2) or IL-15, whereas other factors (stem cell factor [SCF], fms-like tyrosine kinase-3 ligand ) induce early HPC expansion and responsiveness to IL-2 and IL-15 signaling. 14 CD34 ϩ HPCs are heterogeneous and include cells at various levels of differentiation. Multipotent HPCs with long-term repopulation potential are contained within the CD34 ϩ CD38 Ϫ subset. 15 More advanced lineage precursors, included in the CD34 ϩ CD38 ϩ fraction, 15 have been categorized as common myeloid progenitor (CMP; CD34 ϩ CD38 ϩ CD123 ϩ CD45RA Ϫ ), granulocyticmonocytic precursor (GMP; (CD34 ϩ CD38 ϩ CD123 ϩ CD45RA ϩ ), and megakaryocyte-erythroid precursor (CD34 ϩ CD38 ϩ CD123 Ϫ CD45RA Ϫ ). 16 Subsets of CD34 ϩ precursors have also been distinguished by their ability to readily differentiate into NK cells. Surface receptors that define NK precursors include CD7, 13 CD122, 17 CD161, 18 integrin 7, and CD45RA high . 19 Stromal cell layers have been used to differentiate HPCs into NK cells. Sources of stroma include bone marrow, 13,20 murine fetal liver cell lines, 21 and human splenic fibroblasts. 22 Stroma increase the efficiency of NK-ce...